AKR1C1保护干眼症中角膜上皮细胞免受氧化应激介导的铁死亡
该研究通过东莨菪碱注射与干燥应激建立干眼症小鼠模型,并在500 mOsM高渗条件下培养人角膜上皮细胞系,发现过度氧化应激诱导的铁死亡参与干眼症发病,AKR1C1由NRF2触发表达以减轻铁死亡所致细胞损伤和炎症。
要点
- 干眼症模型中角膜上皮细胞出现铁死亡相关标志物表达改变、细胞内铁蓄积和脂质过氧化。
- 抑制过度氧化应激可减少高渗诱导的角膜上皮细胞铁含量和脂质过氧化水平。
- AKR1C1敲低降低细胞活力并增加脂质过氧化,过表达产生相反结果;体内抑制AKR1C1促进角膜缺损和炎症反应。
核心结论
- 过度氧化应激诱导的铁死亡参与干眼症发病机制。
- AKR1C1表达由NRF2触发,减少角膜上皮细胞中铁死亡所致细胞损伤和炎症。
- 这些发现可能为干眼症治疗提供靶向铁死亡和AKR1C1的潜在标志物。
研究设计与样本
- C57BL/6小鼠皮下注射东莨菪碱并暴露于干燥应激以建立干眼症小鼠模型。
- 永生化人角膜上皮细胞系在500 mOsM高渗条件下培养。
主要发现
- 干眼症模型角膜上皮细胞中观察到铁死亡相关标志物表达明显改变、细胞内铁蓄积和脂质过氧化。
- 抑制过度氧化应激后,高渗诱导的人角膜上皮细胞铁死亡受到抑制,表现为铁含量和脂质过氧化水平降低。
- 高渗条件下人角膜上皮细胞中AKR1C1通过NRF2激活而上调。
- AKR1C1敲低后细胞活力降低并伴脂质过氧化增加,过表达则产生相反结果。
- 体内抑制AKR1C1后角膜缺损和炎症反应加重。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the precise mode of cell death and to investigate the molecular mechanism underlying the initiation of inflammation in dry eye disease (DED). METHODS: C57BL/6 mice were injected with scopolamine subcutaneously and exposed to desiccating stress to establish a DED mouse model. An immortalized human corneal epithelial cell line (HCEC) was cultured under hyperosmolarity (500 mOsM). Protein expressions were measured using western blot assay and immunofluorescence staining. mRNA expression was analyzed by RNA-sequencing and quantitative RT-PCR. Transmission electron microscopy was used to observe the intracellular ultrastructure. Intracellular Fe2+ was detected by a FerroOrange fluorescent probe. Flow cytometry was used to evaluate the cellular reactive oxygen species and lipid peroxidation. RESULTS: Marked changes in ferroptosis-related markers expression, intracellular iron accumulation, and lipid peroxidation were observed in corneal epithelial cells of DED models. When excessive oxidative stress was suppressed, ferroptosis induced by hyperosmolarity in HCECs was restrained, as indicated by decreased iron content and lipid peroxidation levels. Moreover, AKR1C1 was upregulated by the activation of NRF2 in HCECs under hyperosmolarity. When AKR1C1 was knocked down, cell viability was decreased, accompanied by increased lipid peroxidation, whereas overexpression of AKR1C1 produced the opposite results. It was observed consistently that corneal defects and the inflammatory response were promoted after inhibition of AKR1C1 in vivo. CONCLUSIONS: Excessive oxidative stress-induced ferroptosis participates in DED pathogenesis. The expression of AKR1C1 is triggered by NRF2 to decrease ferroptosis-induced cell damage and inflammation in HCECs. These findings may provide potential makers targeting ferroptosis and AKR1C1 for DED therapy.
引用
- Zuo X, Zeng H, Wang B, et al. AKR1C1 Protects Corneal Epithelial Cells Against Oxidative Stress-Mediated Ferroptosis in Dry Eye. Invest Ophthalmol Vis Sci. 2022. PMID: 36066316. doi:10.1167/iovs.63.10.3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。